These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma. Andersen MN; Andersen NF; Rødgaard-Hansen S; Hokland M; Abildgaard N; Møller HJ Leuk Res; 2015 Sep; 39(9):971-5. PubMed ID: 26169445 [TBL] [Abstract][Full Text] [Related]
3. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782 [TBL] [Abstract][Full Text] [Related]
4. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Davis BH; Zarev PV Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200 [TBL] [Abstract][Full Text] [Related]
5. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease. Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048 [TBL] [Abstract][Full Text] [Related]
6. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028 [TBL] [Abstract][Full Text] [Related]
9. Serum soluble CD163 levels in patients with influenza-associated encephalopathy. Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Ishida C; Tanaka S; Morishima T; Ichiyama T Brain Dev; 2013 Aug; 35(7):626-9. PubMed ID: 23149357 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients. Tanimura H; Mizuno K; Okamoto H Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688 [TBL] [Abstract][Full Text] [Related]
11. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy. Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Andrys C Allergol Immunopathol (Madr); 2013; 41(3):158-62. PubMed ID: 22765877 [TBL] [Abstract][Full Text] [Related]
12. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400 [TBL] [Abstract][Full Text] [Related]
13. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432 [TBL] [Abstract][Full Text] [Related]
14. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis. Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926 [TBL] [Abstract][Full Text] [Related]
16. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146 [TBL] [Abstract][Full Text] [Related]
17. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding. Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020 [TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505 [TBL] [Abstract][Full Text] [Related]
19. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405 [TBL] [Abstract][Full Text] [Related]
20. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Møller HJ; de Fost M; Aerts H; Hollak C; Moestrup SK Eur J Haematol; 2004 Feb; 72(2):135-9. PubMed ID: 14962251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]